PubMed · 1981 · 34 citations · 11 references
MedicineOphthalmologySurgeryOcular ImmunologyOphthalmic SurgeryTransplant ImmunologyAllograft RejectionCorneal DiseaseCorneal TransplantationCorneal VascularizationGraft RejectionTransplant RejectionCorneal Graft RejectionCorneal GraftingOcular Corneal Allograft RejectionShared Antigenic Determinants
Corneal grafting has been attempted for 200 years. Greatly improved results in recent years have been attributed to developments in anaesthesia, asepsis, and immunological and anti-inflammatory therapy. The important factors affecting the outcome of corneal grafting today are the degree of vascularisation of the cornea before surgery, the inflammatory status at the time of surgery, and the number of antigenic determinants shared by donor and host. Allograft rejection is the most common cause of corneal graft failure. Animal experiments suggest that cyclosporin A given at the time of surgery is likely to prove the most effective means available for preventing corneal graft rejection. Although the introduction of more specific immunosuppressive agents is important, the development of techniques to improve the environment of the outer eye demands the highest priority. Corneal disease is the commonest cause of blindness on a world scale, but many patients are unacceptable for grafting with the currently accepted criteria for operability.
11
CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MAN
R Powles, H.M. Clink, John Sloane et al. · The Lancet · 1978 · 212 citations
PROLONGED SURVIVAL OF PIG ORTHOTOPIC HEART GRAFTS TREATED WITH CYCLOSPORIN A
R. Y. Calne, David J. White, Keith Rolles et al. · The Lancet · 1978 · 206 citations
Medicine, Cardiology, Surgery +8
HLA MATCHING AND CORNEAL GRAFTING
J. R. Batchelor, Thomas A. Casey, David C. Gibbs et al. · The Lancet · 1976 · 156 citations
Medicine, Ophthalmology, Surgery +12